Standard Methotrexate Dosage
Methotrexate dosing varies by condition, such as rheumatoid arthritis (RA), psoriasis, or cancer. For RA in adults, it's typically 7.5–25 mg once weekly, often oral or subcutaneous. Higher doses (up to 30–35 mg/week) apply for psoriasis. Cancer regimens use much higher intravenous doses (e.g., 1–12 g/m²) with leucovorin rescue.
Adjustments for Elderly Patients
Elderly patients (over 65) require lower starting doses due to reduced kidney function, higher toxicity risk, and comorbidities. Guidelines recommend initiating at 7.5 mg/week or less for RA, titrating slowly while monitoring. Renal impairment (common in 30–50% of elderly) prompts dose cuts: reduce by 30–50% if creatinine clearance is 30–60 mL/min, or avoid if below 30 mL/min.[1][2]
Why Dosage Changes in the Elderly
Age-related declines in glomerular filtration rate (GFR) prolong methotrexate clearance, raising risks of myelosuppression, hepatotoxicity, and mucositis. Studies show elderly patients experience 2–3 times higher toxicity rates at standard doses. Body composition shifts (less muscle, more fat) alter drug distribution.[1][3]
Monitoring and Safety for Seniors
Check baseline CBC, liver enzymes, and serum creatinine before starting, then weekly initially. Use Cockcroft-Gault for GFR estimation. Folic acid (1–5 mg/day) reduces side effects across ages but is critical in elderly. Avoid NSAIDs or proton pump inhibitors that interact.[2][4]
Differences by Condition
- Rheumatoid Arthritis: Elderly start at 5–7.5 mg/week vs. 7.5–15 mg in younger adults.
- Psoriasis: Cap at 15–20 mg/week, lower than 25–30 mg standard.
- Cancer: High-dose regimens rare in elderly; prefer alternatives like pemetrexed if feasible.[1][3]
Common Side Effects in Elderly
GI upset, fatigue, and infections occur more frequently. Severe risks like pancytopenia rise with even modest doses. Hospitalization rates for toxicity are 5–10% higher in those over 75.[4]
Sources
[1]: American College of Rheumatology RA Guidelines (2021)
[2]: FDA Methotrexate Label
[3]: UpToDate: Methotrexate in Older Adults
[4]: PubMed: Toxicity in Elderly (Review, 2018)